Intraocular Melanoma Completed Phase 3 Trials for Melphalan (DB01042)

Also known as: Intraocular melanoma NOS

IndicationStatusPhase
DBCOND0028574 (Intraocular Melanoma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00324727Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to MelanomaTreatment